MANUS BIO INC.

Profile

Company Names

MANUS BIO INC.
MANUS BIOSYNTHESIS, INC.

Addresses

43 FOUNDRY AVENUE, #230, WALTHAM, MA 02453

1030 MASSSACHUSETTS AVENUE, SUITE 300, CAMBRIDGE, MA 02138

Phone Numbers

617-299-8466
857-891-1761

 

Entity Type:

CORPORATION

Industry:

OTHER, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$184,220,903.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2024-04-08 
$11,270,003.00 
$11,270,003.00 
$0.00 
Equity 
6
2021-08-20 
$21,225,000.00 
$22,286,250.00 
$1,061,250.00 
Equity, Debt 
5
2020-08-20 
$66,187,702.00 
$80,050,000.00 
$13,862,298.00 
Equity 
4
2020-04-16 
$66,187,702.00 
$80,050,000.00 
$13,862,298.00 
Equity 
3
2018-06-12 
$10,000,000.00 
$12,000,000.00 
$2,000,000.00 
Equity 
2
2017-08-31 
$9,050,496.00 
$10,000,000.00 
$949,504.00 
Equity 
1
2016-09-30 
$300,000.00 
$3,000,000.00 
$2,700,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRYON 
 
ALSBERG 
DIRECTOR
BYRON 
 
ALSBERG 
DIRECTOR
JEFF 
 
ANDERSON 
EXECUTIVE OFFICER
CARSTEN 
 
BOERS 
DIRECTOR
PAUL 
 
BONI 
EXECUTIVE OFFICER
MICHAEL 
 
CARLOS 
DIRECTOR
RICK 
 
GERSON 
DIRECTOR
RICHARD 
 
GOLDSTEIN 
DIRECTOR
COLIN 
 
GOUNDEN 
DIRECTOR
JEREMIAH 
 
HUX 
EXECUTIVE OFFICER
ALENA 
 
IVASHENKA 
DIRECTOR
AJIKUMAR 
PARAYIL 
KUMARAN 
DIRECTOR, EXECUTIVE OFFICER
ZANNA 
 
MCFERSON 
DIRECTOR
JEAN 
 
NEHME 
DIRECTOR
JOHN 
 
NEHME 
DIRECTOR
AJIKUMAR 
 
PARAYIL 
EXECUTIVE OFFICER, DIRECTOR
JULIO 
A. 
RUIZ CALDERON 
EXECUTIVE OFFICER
CHRISTINE 
 
SANTOS 
EXECUTIVE OFFICER
GREGORY 
 
STEPHANOPOULOS 
DIRECTOR
JASON 
 
WHALEY 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-04-08 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-08-20 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-16 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-20 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-12 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#